Chondrosarcoma
Showing 1 - 25 of 166
Engagement Trends in Chondrosarcoma Clinical Trials
Not yet recruiting
- Chondrosarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 1, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
Periosteal Chondrosarcoma: a Single Institution Experience
Completed
- Periosteal Chondrosarcoma
-
Bologna, ItalyIRCCS- Istituto Ortopedico Rizzoli
Aug 22, 2022
Chondrosarcoma Trial in Houston (Proton Beam Therapy)
Active, not recruiting
- Chondrosarcoma
- Proton Beam Therapy
-
Houston, TexasMD Anderson Cancer Center
Aug 25, 2022
Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma Trial in France (Laboratory
Active, not recruiting
- Clear Cell Chondrosarcoma
- +6 more
- Laboratory Biomarker Analysis
- +2 more
-
Bordeaux, France
- +5 more
Sep 20, 2022
Conventional Chondrosarcoma, Myxoid Liposarcoma, Mesenchymal Chondrosarcoma Trial in Netherlands, Spain (sirolimus and
Completed
- Conventional Chondrosarcoma
- +3 more
- sirolimus and cyclophosphamide
-
Leiden, Netherlands
- +6 more
Apr 19, 2022
Chondrosarcoma Trial in Iowa City (Zoledronic Acid)
Recruiting
- Chondrosarcoma
- Zoledronic Acid
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Mar 16, 2022
Chondrosarcoma Trial (Anlotinib HCl, PD-1 inhibitor)
Not yet recruiting
- Chondrosarcoma
- Anlotinib hydrochloride
- PD-1 inhibitor
- (no location specified)
Dec 31, 2021
Chordoma, Chondrosarcoma, Ewing Sarcoma Trial in Nice (Proteus ONE one daily beam, Proteus ONE two daily beam)
Recruiting
- Chordoma
- +3 more
- Proteus ONE one daily beam
- Proteus ONE two daily beam
-
Nice, FranceCentre Antoine lacassagne
Sep 14, 2023
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Chordoma, Chondrosarcoma Trial in Madrid (5-fraction hipofractionated protontheray)
Recruiting
- Chordoma
- Chondrosarcoma
- 5-fraction hipofractionated protontheray
-
Madrid, SpainCentro de Protonterapia Quironsalud
May 15, 2023
Personalized Home Exercise Program in Bone Tumor Undergoing
Recruiting
- Osteosarcoma
- +3 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 21, 2023
Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)
Active, not recruiting
- Mesenchymal Chondrosarcoma
-
Prato, Firenze, Italy
- +5 more
Oct 29, 2021
Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)
Active, not recruiting
- Solitary Fibrous Tumor
- Extraskeletal Myxoid Chondrosarcoma
-
Palma De Mallorca, Islas Baleares, Spain
- +6 more
Jan 31, 2022
Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary
Suspended
- Locally Advanced Unresectable Primary Central Chondrosarcoma
- +2 more
- Belinostat
- +5 more
-
Phoenix, Arizona
- +38 more
Feb 2, 2023
Image Assisted Optimization of Proton Radiation Therapy in
Recruiting
- Bone Neoplasm of Vertebral Column
- +5 more
-
Delft, South Holland, Netherlands
- +1 more
Apr 5, 2022
Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,
Not yet recruiting
- Metastatic Extraskeletal Myxoid Chondrosarcoma
- +3 more
- Biopsy
- +6 more
- (no location specified)
Apr 25, 2023
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Chordomas, Chondrosarcomas Trial in Philadelphia (Proton Therapy)
Active, not recruiting
- Chordomas
- Chondrosarcomas
- Proton Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 2, 2022
Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed
Not yet recruiting
- Pediatric Cancer
- +11 more
- anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
-
Milwaukee, WisconsinChildren's Wisconsin
Sep 14, 2022
Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)
Available
- Pancreatic Cancer
- +6 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center, LLC
Jan 20, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)
Enrolling by invitation
- Ewing Sarcoma
- +8 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Feb 23, 2022